These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease. Tamula MA; Wolters PL; Walsek C; Zeichner S; Civitello L Pediatrics; 2003 Sep; 112(3 Pt 1):679-84. PubMed ID: 12949303 [TBL] [Abstract][Full Text] [Related]
25. Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India. Srikanth P; Castillo RC; Sridharan G; John TJ; Zachariah A; Mathai D; Schwartz DH Int J STD AIDS; 2000 Jan; 11(1):49-51. PubMed ID: 10667901 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. Cysique LA; Maruff P; Brew BJ J Neurovirol; 2004 Dec; 10(6):350-7. PubMed ID: 15765806 [TBL] [Abstract][Full Text] [Related]
27. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. Cysique LA; Letendre SL; Ake C; Jin H; Franklin DR; Gupta S; Shi C; Yu X; Wu Z; Abramson IS; Grant I; Heaton RK; AIDS; 2010 Apr; 24(7):983-90. PubMed ID: 20299964 [TBL] [Abstract][Full Text] [Related]
28. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. Garvey LJ; Yerrakalva D; Winston A AIDS Res Hum Retroviruses; 2009 Aug; 25(8):765-9. PubMed ID: 19678764 [TBL] [Abstract][Full Text] [Related]
29. Neurocognitive functioning of HIV positive children attending the comprehensive care clinic at Kenyatta national hospital: exploring neurocognitive deficits and psychosocial risk factors. Musindo O; Bangirana P; Kigamwa P; Okoth R; Kumar M AIDS Care; 2018 May; 30(5):618-622. PubMed ID: 29353495 [TBL] [Abstract][Full Text] [Related]
30. Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients. Tate DF; Delong A; McCaffrey DE; Kertesz K; Paul RH; Conley J; Russell T; Coop K; Gillani F; Flanigan T; Tashima K; Hogan JW Arch Clin Neuropsychol; 2011 Nov; 26(7):614-23. PubMed ID: 21873325 [TBL] [Abstract][Full Text] [Related]
31. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. Cohen RA; Boland R; Paul R; Tashima KT; Schoenbaum EE; Celentano DD; Schuman P; Smith DK; Carpenter CC AIDS; 2001 Feb; 15(3):341-5. PubMed ID: 11273214 [TBL] [Abstract][Full Text] [Related]
33. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. McCutchan JA; Wu JW; Robertson K; Koletar SL; Ellis RJ; Cohn S; Taylor M; Woods S; Heaton R; Currier J; Williams PL AIDS; 2007 May; 21(9):1109-17. PubMed ID: 17502721 [TBL] [Abstract][Full Text] [Related]
34. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764 [TBL] [Abstract][Full Text] [Related]
35. Memory performance in HIV/AIDS--a prospective case control study. Odiase FE; Ogunrin OA; Ogunniyi AA Can J Neurol Sci; 2007 May; 34(2):154-9. PubMed ID: 17598591 [TBL] [Abstract][Full Text] [Related]
37. Viral burden and disease progression in HIV-1-infected patients with sickle cell anemia. Bagasra O; Steiner RM; Ballas SK; Castro O; Dornadula G; Embury S; Jungkind D; Bobroski L; Kutlar A; Burchott S Am J Hematol; 1998 Nov; 59(3):199-207. PubMed ID: 9798657 [TBL] [Abstract][Full Text] [Related]
38. Early central nervous system response to HIV infection: sleep distortion and cognitive-motor decrements. White JL; Darko DF; Brown SJ; Miller JC; Hayduk R; Kelly T; Mitler MM AIDS; 1995 Sep; 9(9):1043-50. PubMed ID: 8527076 [TBL] [Abstract][Full Text] [Related]
39. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
40. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy. Gandhi T; Wei W; Amin K; Kazanjian P Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]